Drug Type Small molecule drug |
Synonyms CU115 |
Target |
Mechanism TLR8 antagonists(Toll like receptor 8 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 05 Nov 2019 |